4 | nafamostatIBA
01/2017
-
07/2014 |
4 | Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2017
-
07/2014 |
3 | DNA (Deoxyribonucleic Acid)IBA
06/2022
-
01/2021 |
3 | Glucose (Dextrose)FDA LinkGeneric
01/2016
-
03/2015 |
3 | Oxygen (Dioxygen)IBA
01/2016
-
03/2015 |
2 | Biomarkers (Surrogate Marker)IBA
05/2022
-
01/2020 |
2 | Antiviral Agents (Antivirals)IBA
01/2022
-
01/2021 |
2 | Interferon Type IIBA
01/2022
-
01/2021 |
2 | IronIBA
12/2021
-
01/2021 |
2 | CytokinesIBA
01/2021
-
11/2015 |
2 | Proteins (Proteins, Gene)FDA Link
01/2021
-
01/2019 |
2 | Amyloid (Amyloid Fibrils)IBA
07/2018
-
03/2016 |
2 | Serine Proteases (Serine Protease)IBA
01/2016
-
07/2014 |
2 | ThrombinFDA Link
01/2016
-
07/2014 |
2 | Glutamic Acid (Glutamate)FDA Link
10/2015
-
03/2015 |
1 | Volatile Fatty AcidsIBA
08/2022 |
1 | WastewaterIBA
08/2022 |
1 | 1- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- oneIBA
06/2022 |
1 | Cadherins (E-Cadherin)IBA
05/2022 |
1 | VimentinIBA
05/2022 |
1 | Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 |
1 | Phosphotransferases (Kinase)IBA
01/2022 |
1 | olaparibIBA
01/2022 |
1 | Long Noncoding RNAIBA
01/2022 |
1 | Tyrosine Kinase InhibitorsIBA
01/2022 |
1 | lorlatinibIBA
01/2022 |
1 | Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022 |
1 | Hexachlorocyclohexane (gamma-Hexachlorocyclohexane)FDA LinkGeneric
05/2021 |
1 | Environmental Pollutants (Pollutants, Environmental)IBA
05/2021 |
1 | 1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
04/2021 |
1 | Vehicle Emissions (Emissions, Vehicle)IBA
04/2021 |
1 | AntioxidantsIBA
04/2021 |
1 | Oxidants (Oxidizing Agents)IBA
04/2021 |
1 | LBQ657IBA
01/2021 |
1 | sacubitrilIBA
01/2021 |
1 | GMP synthase (glutamine-hydrolyzing)IBA
01/2021 |
1 | sacubitril and valsartan sodium hydrate drug combinationIBA
01/2021 |
1 | 2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
01/2021 |
1 | cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2021 |
1 | Cyclic AMP (AMP, Cyclic)IBA
01/2021 |
1 | InterferonsIBA
01/2021 |
1 | Silver Sulfadiazine (SSD)FDA LinkGeneric
01/2021 |
1 | Tobacco Smoke Pollution (Passive Smoking)IBA
01/2021 |
1 | Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 |
1 | Interleukin-8 (Interleukin 8)IBA
01/2021 |
1 | AnkyrinsIBA
01/2021 |
1 | Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021 |
1 | Transient Receptor Potential ChannelsIBA
01/2021 |
1 | Viral RNAIBA
12/2020 |
1 | gadolinium ethoxybenzyl DTPAFDA Link
01/2020 |
1 | SteroidsIBA
01/2020 |
1 | GadoliniumIBA
01/2020 |
1 | Pentetic Acid (DTPA)FDA LinkGeneric
01/2020 |
1 | Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 |
1 | Saline SolutionIBA
01/2020 |
1 | Hydrogen Cyanide (Zyklon B)IBA
03/2019 |
1 | GlucosidesIBA
03/2019 |